药明康德 港股通 空最新增减持 (2026-01-14) 官网 ( 02359.hk) | 21.54 | 4.45 | 1.52% | 上市时间2018-12-13股价115.60港币涨跌幅1.76%成交金额11.30亿港币换手率0.33%市值3,449.22亿港币H股市值590.11亿港币总股本29.84亿H股本5.10亿每手股数100上市至今年化投资收益率23.06%港股通持仓占H股比例14.34% (83.17亿港币2026-01-27) 累计做空占H股比例8.75% (54.03亿港币2026-01-16) | |||
| 所属三级行业生物技术 (恒生) | 市盈率 | 67.63 | 市净率 | 5.13 | 股息率 | 0.30% | 恒生:医疗保健业药品及生物科技生物技术 |
| 所属指数指数纳入纳出 | |||||||
| 同股同权 | 查看历史折扣 | ||||||
| 备注 (7): | 双击编辑备注 |
药明康德(02359) - 历史董事名单
| # | 姓名 | 职衔 | 职位 | 委任日期 | 辞任日期 |
|---|---|---|---|---|---|
| 1 | 盧韶華 | Independent Non Executive Director - A/F | 2023-05-31 | -- | |
| 2 | 俞衛 | Independent Non Executive Director | 2023-05-31 | -- | |
| 3 | 詹智玲 | Independent Non Executive Director | 2023-05-31 | -- | |
| 4 | 張新 | Independent Non Executive Director | 2023-05-31 | -- | |
| 5 | 陳民章 | Executive Director | CEO | 2022-05-06 | -- |
| 6 | 杨青 | Executive Director | CEO | 2020-05-15 | -- |
| 7 | 馮岱 | Independent Non Executive Director | 2018-08-22 | -- | |
| 8 | 蔡江南 | Independent Non Executive Director | 2017-03-17 | 2023-05-31 | |
| 9 | 劉艷 | Independent Non Executive Director | 2017-03-17 | 2023-05-31 | |
| 10 | 胡正國 | Executive Director | 2017-03-01 | -- | |
| 11 | 李革 | Executive Director | Chairman, CEO | 2017-03-01 | -- |
| 12 | 童小幪 | Non Executive Director | 2017-03-01 | -- | |
| 13 | 吳亦兵 | Non Executive Director | 2017-03-01 | -- | |
| 14 | 張朝暉 | Executive Director | 2017-03-01 | -- | |
| 15 | 婁賀統 | Independent Non Executive Director | 2017-03-01 | 2023-05-31 | |
| 16 | 張曉彤 | Independent Non Executive Director | 2017-03-01 | 2023-05-31 | |
| 17 | 趙寧 | Executive Director | 2017-03-01 | 2023-05-16 | |
| 18 | 劉曉鐘 | Executive Director | 2017-03-01 | 2020-03-24 |